Hanmin Li
Impact in
- Hepatology top 10%
- Liver physiology and pathology
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
Papers in
- Hepatology 13
- Liver physiology and pathology 10
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Co-authors
- Meimei Wu (4 shared papers)Zhihua Ye (7 shared papers)Fuhua Wang (2 shared papers)Yingqiong Du (1 shared paper)Zhichao Wu (1 shared paper)Yu Peng (2 shared papers)Xin Shen (2 shared papers)Shuai Liu (1 shared paper)
- Journals
- Evidence-based Complementary and Alternative Medicine (4 papers)Chinese Journal of Integrative Medicine (2 papers)World Journal of Gastroenterology (2 papers)Oncotarget (2 papers)Frontiers of Medicine (2 papers)
- Partner nations
- ChinaSwitzerlandIran
In The Last Decade
Hanmin Li
36 papers receiving 598 citations
Peers
Comparison fields: 5 of 91
- Hepatology 88
- Molecular Medicine 41
- Pharmacology 66
- Pollution 56
- Cancer Research 51
Countries citing papers authored by Hanmin Li
This map shows the geographic impact of Hanmin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanmin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanmin Li more than expected).
Fields of papers citing papers by Hanmin Li
This network shows the impact of papers produced by Hanmin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanmin Li. The network helps show where Hanmin Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Hanmin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 149 | |
| 2 | 2018 | 53 | |
| 3 | 2017 | 36 | |
| 4 | 2017 | 34 | |
| 5 | 2016 | 26 | |
| 6 | 2018 | 25 | |
| 7 | 2014 | 25 | |
| 8 | 2017 | 24 | |
| 9 | 2016 | 22 | |
| 10 | Curcumin combined with glycyrrhetinic acid inhibits the development of hepatocellular carcinoma cells by down-regulating the PTEN/PI3K/AKT signalling pathway. | 2017 | 20 |
| 11 | 2015 | 18 | |
| 12 | 2018 | 17 | |
| 13 | 2020 | 16 | |
| 14 | 2020 | 14 | |
| 15 | 2020 | 12 | |
| 16 | Diwu Yanggan capsule improving liver histological response for patients with HBeAg-negative chronic hepatitis B: a randomized controlled clinical trial. | 2018 | 12 |
| 17 | 2017 | 11 | |
| 18 | 2004 | 10 | |
| 19 | 2014 | 10 | |
| 20 | Diwu Yanggan capsule inhibits the occurrence and development of liver cancer in the Solt-Farber rat model by regulating the Ras/Raf/Mek/Erk signaling pathway. | 2018 | 9 |
About Hanmin Li
Hanmin Li is a scholar working on Hepatology, Molecular Biology, Pharmacology, Epidemiology and Surgery, having authored 36 papers that have together received 602 indexed citations. Recurring topics across this work include Liver physiology and pathology (10 papers), Liver Disease Diagnosis and Treatment (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Pharmacological Effects of Natural Compounds (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Hepatitis B Virus Studies (3 papers), Cancer Mechanisms and Therapy (3 papers) and Curcumin's Biomedical Applications (3 papers). The work is most often cited by research in Hepatology (88 citations), Molecular Medicine (41 citations), Pharmacology (66 citations), Pollution (56 citations) and Cancer Research (51 citations). Hanmin Li has collaborated with scholars based in China, Switzerland and Iran. Frequent co-authors include Meimei Wu, Zhihua Ye, Fuhua Wang, Yingqiong Du, Zhichao Wu, Yu Peng, Xin Shen, Shuai Liu, Jie Zhao and Dian Wen. Their work appears in journals such as Evidence-based Complementary and Alternative Medicine, Chinese Journal of Integrative Medicine, World Journal of Gastroenterology, Oncotarget and Frontiers of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.